Avadel Pharmaceuticals Plc Stock Market Value
| AVDL Stock | USD 11.22 0.44 3.77% |
| Symbol | Avadel |
Avadel Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share 1.036 | Quarterly Revenue Growth 26.743 | Return On Assets (0.34) | Return On Equity (1.00) |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Avadel Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Avadel Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Avadel Pharmaceuticals.
| 12/07/2022 |
| 11/26/2024 |
If you would invest 0.00 in Avadel Pharmaceuticals on December 7, 2022 and sell it all today you would earn a total of 0.00 from holding Avadel Pharmaceuticals PLC or generate 0.0% return on investment in Avadel Pharmaceuticals over 720 days. Avadel Pharmaceuticals is related to or competes with Neurocrine Biosciences, Ironwood Pharmaceuticals, Alkermes Plc, Intracellular, Dynavax Technologies, Journey Medical, and Evoke Pharma. Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States More
Avadel Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Avadel Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Avadel Pharmaceuticals PLC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 39.15 | |||
| Value At Risk | (5.87) | |||
| Potential Upside | 4.18 |
Avadel Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avadel Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Avadel Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Avadel Pharmaceuticals historical prices to predict the future Avadel Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.38) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Avadel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Avadel Pharmaceuticals Backtested Returns
Avadel Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0809, which signifies that the company had a -0.0809% return per unit of standard deviation over the last 3 months. Avadel Pharmaceuticals PLC exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Avadel Pharmaceuticals' risk adjusted performance of (0.06), and Mean Deviation of 2.42 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.09, which signifies a somewhat significant risk relative to the market. Avadel Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Avadel Pharmaceuticals is expected to follow. At this point, Avadel Pharmaceuticals has a negative expected return of -0.35%. Please make sure to confirm Avadel Pharmaceuticals' treynor ratio, and the relationship between the standard deviation and kurtosis , to decide if Avadel Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.30 |
Below average predictability
Avadel Pharmaceuticals PLC has below average predictability. Overlapping area represents the amount of predictability between Avadel Pharmaceuticals time series from 7th of December 2022 to 2nd of December 2023 and 2nd of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Avadel Pharmaceuticals price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current Avadel Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.3 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 2.55 |
Avadel Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Avadel Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Avadel Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Avadel Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Avadel Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Avadel Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Avadel Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Avadel Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Avadel Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Avadel Pharmaceuticals Lagged Returns
When evaluating Avadel Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Avadel Pharmaceuticals stock have on its future price. Avadel Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Avadel Pharmaceuticals autocorrelation shows the relationship between Avadel Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Avadel Pharmaceuticals PLC.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Avadel Pharmaceuticals Correlation, Avadel Pharmaceuticals Volatility and Avadel Pharmaceuticals Alpha and Beta module to complement your research on Avadel Pharmaceuticals. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Avadel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.